<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OTO</journal-id>
<journal-id journal-id-type="hwp">spoto</journal-id>
<journal-title>Otolaryngology–Head and Neck Surgery</journal-title>
<issn pub-type="ppub">0194-5998</issn>
<issn pub-type="epub">1097-6817</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0194599812446789</article-id>
<article-id pub-id-type="publisher-id">10.1177_0194599812446789</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Letters to the Editor</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cost-Effectiveness in Otolaryngology</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Shrime</surname><given-names>Mark G.</given-names></name>
<degrees>MD, MPH</degrees>
</contrib>
</contrib-group>
<author-notes>
<corresp id="corresp1-0194599812446789">Harvard Interfaculty Initiative in Health Policy, Cambridge, Massachusetts, USA Email: <email>shrime@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>7</month>
<year>2012</year>
</pub-date>
<volume>147</volume>
<issue>1</issue>
<fpage>180</fpage>
<lpage>181</lpage>
<permissions>
<copyright-statement>© American Academy of Otolaryngology—Head and Neck Surgery Foundation 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Official journal of the American Academy of Otolaryngology–Head and Neck Surgery Foundation</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p>Singer et al have published a case series of 307 patients undergoing total or completion thyroidectomy whom they have treated with postoperative calcium carbonate supplementation without biochemical assays of either calcium or parathyroid hormone levels.<sup><xref ref-type="bibr" rid="bibr1-0194599812446789">1</xref></sup> They find that only 7.5% of their patients required additional supplementation, and only 2 (0.65%) required admission using this protocol. Because they assert that the cost of a 3-week regimen of calcium supplementation is $15, compared with up to $293 for biochemical parathyroid hormone assays, they conclude that “prophylactic calcium supplementation without routine laboratory assessment proved to be . . . safe and cost-effective.”</p>
<p>Unfortunately, their data do not support this claim.</p>
<p>“Cost-effective” does not mean “cheapest” (see, for example, Russell et al<sup><xref ref-type="bibr" rid="bibr2-0194599812446789">2</xref></sup>). For an intervention to be cost-effective, it must either be less costly and more effective than its competitor intervention or more costly and more effective than its competitor. By these metrics, immediate calcium supplementation does not necessarily qualify as a cost-effective intervention.</p>
<p>The authors do not give enough information for a rigorous cost-effectiveness analysis to be performed on their data. However, making a few assumptions (that biochemical testing decreases the risk of hypocalcemia, both inpatient and outpatient; that the authors’ probabilities are applicable to the general population; that the authors’ costs are correct; and that the cost of a hospital admission is not zero, which it is implicitly assumed to be in the authors’ article), supplementation without biochemical assays is cost-effective only across a small range of probabilities and costs. Ionized calcium testing is more cost-effective than supplementation across a very reasonable set of probabilities and costs (<xref ref-type="fig" rid="fig1-0194599812446789"><bold>Figure 1</bold></xref>), many of which are similar to those found in the published literature.<sup><xref ref-type="bibr" rid="bibr3-0194599812446789">3</xref></sup></p>
<fig id="fig1-0194599812446789" position="float">
<label>Figure 1.</label>
<caption>
<p>Cost-effective strategies by probability of hospital admission and cost of a hospital admission. The most cost-effective strategy at any combination of probability and cost is color-coded according to the legend at right. Ionized calcium assays are the most cost-effective strategy across a broad range of costs and probabilities.</p>
</caption>
<graphic xlink:href="10.1177_0194599812446789-fig1.tif"/>
</fig>
<p>While it is true that the nominal cost of calcium supplementation is lower than the nominal cost of biochemical assays, it is erroneous to claim that it is therefore a more cost-effective intervention.</p>
<sec id="section1-0194599812446789">
<title>Disclosures</title>
<p><bold>Competing interests</bold>: None.</p>
<p><bold>Sponsorships</bold>: None.</p>
<p><bold>Funding source</bold>: None.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="bibr1-0194599812446789">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Singer</surname><given-names>MC</given-names></name>
<name><surname>Bhakta</surname><given-names>D</given-names></name>
<name><surname>Seybt</surname><given-names>MW</given-names></name>
<name><surname>Terris</surname><given-names>DJ</given-names></name>
</person-group>. <article-title>Calcium management after thyroidectomy: a simple and cost-effective method</article-title>. <source>Otolaryngol Head Neck Surg</source>. <year>2012</year>;<volume>146</volume>:<fpage>362</fpage>-<lpage>365</lpage>.</citation>
</ref>
<ref id="bibr2-0194599812446789">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Russell</surname><given-names>LB</given-names></name>
<name><surname>Gold</surname><given-names>MR</given-names></name>
<name><surname>Siegel</surname><given-names>JE</given-names></name>
<name><surname>Daniels</surname><given-names>N</given-names></name>
<name><surname>Weinstein</surname><given-names>MC</given-names></name>
</person-group>. <article-title>The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine</article-title>. <source>JAMA</source>. <year>1996</year>;<volume>276</volume>:<fpage>1172</fpage>-<lpage>1177</lpage>.</citation>
</ref>
<ref id="bibr3-0194599812446789">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shrime</surname><given-names>MG</given-names></name>
<name><surname>Goldstein</surname><given-names>DP</given-names></name>
<name><surname>Seaberg</surname><given-names>RM</given-names></name>
<etal/>
</person-group>. <article-title>Cost-effective management of low-risk papillary thyroid carcinoma</article-title>. <source>Arch Otolaryngol Head Neck Surg</source>. <year>2007</year>;<volume>133</volume>:<fpage>1245</fpage>-<lpage>1253</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>